ArticleExperimental hematology & oncology2023

A novel CAR-T cell product targeting CD74 is an effective therapeutic approach in preclinical mantle cell lymphoma models.

Wing Keung Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.